Newsroom_PressReleases_subhead

In the news

Press releases

Stories

Prime Insights

Media resources

Section divider

   2020

Sept. 16, 2020

Prime Therapeutics Adds Rx Savings Solutions Tool to Bring Visibility to Prescription Drug Prices, Aims to Improve Consumer Experience

Tool gives members immediate cost savings opportunities and concierge prescription switch support.


Sept. 15, 2020

Ken Paulus of Prime Therapeutics becomes chairman of PCMA Board of Directors

Paulus honored to take on this role within our industry at this important time.


Sept. 3, 2020

Prime Therapeutics teams with RxRevu to deploy Real Time Benefit Check Solution 

Real time information about available drug options helps to bring down costs and create a more positive pharmacy experience. 


 Sept. 2, 2020

Prime Therapeutics Introduces Real Time Benefit Check Solution with DrFirst

Technology enables informed prescribing and aims to enhance member experience within clinicians’ workflows.


Aug. 3, 2020

Horizon, Prime Therapeutics team with PillPack to improve members’ pharmacy experience

New pharmacy option by New Jersey’s largest health insurer offers a simplified signup with PillPack, including member cost information upfront


July 15, 2020

Successful work from home transition at COVID-19 onset allows Prime Therapeutics to create fully remote workforce in Albuquerque

This change will help Prime operate as efficiently as possible without sacrificing performance, productivity and morale.


June 8, 2020

Prime Therapeutics and EMD Serono ink value-based agreement on MAVENCLAD® (cladribine) tablets

Contract brings guaranteed value to payers, aims to improve patient experience.


April 23, 2020

Kyle Skiermont to join Prime Therapeutics as senior vice president, specialty pharmacy and home delivery services

Skiermont will lead Prime’s future strategy for specialty pharmacy and home delivery services.


April 17, 2020

Recent Prime study finds hereditary angioedema drug therapy costs are unsustainable

Real-world data shows six months of drug cost runs $335,000 or more.


April 16, 2020

Study Finds Number of Asthma Biologic Medication Users and Spend Doubled Over 2.5 Years

Real-world data shows patients have low persistence rates.


April 15, 2020

Managed care pharmacist program sees 9:1 return on investment

Prime Therapeutics saves health plan clients a net $2.4 million savings in one year.


April 14, 2020

Regence Health Plans, Prime Therapeutics study shows significant improvements when integrating pharmacy and medical benefits

“Carve-in” model, where health plan and PBM are integrated, can potentially save members a trip to the ER or hospital, and lower medical expenses for employers.


 April 8, 2020

Prime Therapeutics welcomes Joseph Leach, M.D. as Chief Medical Officer 

Oncology physician to expand Prime’s specialty capabilities, total drug management evolution.

 April 8, 2020

Prime Therapeutics Welcomes Joseph Leach, M.D. as Chief Medical Officer 

Oncology physician to expand Prime’s specialty capabilities, total drug management evolution

 April 8, 2020

Prime Therapeutics Welcomes Joseph Leach, M.D. as Chief Medical Officer 

Oncology physician to expand Prime’s specialty capabilities, total drug management evolution

 April 8, 2020

Prime Therapeutics Welcomes Joseph Leach, M.D. as Chief Medical Officer 

Oncology physician to expand Prime’s specialty capabilities, total drug management evolution

 April 8, 2020

Prime Therapeutics Welcomes Joseph Leach, M.D. as Chief Medical Officer 

Oncology physician to expand Prime’s specialty capabilities, total drug management evolution


April 6, 2020

Prime Therapeutics launches PreserveRxSM gene therapy financial protection

New offering helps protect health plans, employers from sudden, one-time claims costs while preserving member access to million-dollar curative gene therapies.


March 30, 2020

Prime Therapeutics hires Stuart Meyerson to lead sales efforts 

Meyerson will guide the execution of the Prime's sales vision, using his expertise to meet growth targets.


March 11, 2020

Prime Therapeutics delivers single-digit pharmacy trend increases for Commercial and Medicare Part D despite increased medication use 

Commercial drug trend held to 4.7% while Medicare Part D trend is nearly flat at 0.1%.


March 10, 2020

Fast Company names Prime Therapeutics among world’s most innovative companies for 2020

Prime and SAS drive innovation to fight industry fraud, waste and abuse with AI.


Jan. 27, 2020

Capital BlueCross advances its precision drug access & cost reduction initiatives with new pharmacy benefit manager 

Prime Therapeutics’ unique assets will help lead innovation in a revolutionary drug era.


Jan. 9, 2020

David Schlett joins Prime Therapeutics as Chief Financial Officer

Schlett is an experienced finance executive with more than 25 years of business, leadership experience.

Jan. 9, 2019

David Schlett Joins Prime Therapeutics as Chief Financial Officer

Schlett is an experienced finance executive with more than 25 years of business, leadership experience.

Jan. 9, 2019

David Schlett Joins Prime Therapeutics as Chief Financial Officer

Schlett is an experienced finance executive with more than 25 years of business, leadership experience.

Jan. 9, 2019

David Schlett Joins Prime Therapeutics as Chief Financial Officer

Schlett is an experienced finance executive with more than 25 years of business, leadership experience.